Amneal Pharmaceuticals Gets US FDA Approvals for Alzheimer's, Oncology Treatments, Gastrointestinal Disease
Cytokinetics Heart Drug's Future Sparks Optimism Despite M&A Hurdles and Royalty Deal Concerns: Analyst
Express News | FDA Adds Boxed Warning About Anaphylaxis With Multiple Sclerosis Medicine Glatiramer Acetate (Copaxone, Glatopa)
Google Parent-Owned Startup To Launch AI-Designed Drug Trials By Year-End, Partnering With Eli Lilly And Novartis To Tackle Major Diseases
The speed of drug research and development has increased by ten times! Google states that the first AI-designed medication will enter testing by the end of the year.
Demis Hassabis, the founder of Google's drug development company, stated that traditional drug development usually takes 5 to 10 years, while with the help of AI technology, this process may be accelerated by 10 times. Former USA Treasury Secretary Summers once commented that AI's relationship with the Internet Plus-Related is similar to that of computers with calculators.
Top Gap Ups and Downs on Tuesday: TEM, MMM, DJT and More
Growth Investor27 : I own a lot & will buy more
DazzlerAus : agree but nothing seems to help
Youngman : I keep hearing nothing but good things about the stock while it goes down lol